Login

Frédéric Gardès' Opening Speech at the Conference: 'Innovations for Smart Mobility | Frédéric Gardès - CEO of Colas Group 00:10:00

Share On Facebook Share On Twitter

Frédéric Gardès is the CEO of Colas Group

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Wise Announces Transaction Fee Hikes for Select Customers Amid Rising Costs | Kristo Käärmann ,CEO , Wise Plc.
00:10:00
SiTime CEO Rajesh Vashist joins Jill Malandrino on Nasdaq #TradeTalks to discuss the precision timing category and its impact.
00:10:00
The Value of Hiring a Financial Advisor: Objectivity and Expertise | Brooklyn Brock, Founder, Ellevate Advisors LLC.
00:10:00
Discussing 'Exile and Social Thought: Hungarian Intellectuals in Germany and Austria, 1919-1933' with Professor Lee Congden|Lee Congdon,Professor,James Madison University
00:10:00
Revolutionizing Therapeutics: Advancements in RNA Medicines|Joseph E. Payne, CEO, Arcturus Therapeutics Holdings Inc.
00:10:00
providing maximum support with minimum interference|John Luttig,Principal,Founders Fund
00:10:00
Kate Richard on Oil Market Dynamics and Investment Strategies at Warwick Energy | Kate Richard, Founder and CEO, Warwick Energy Group.
00:10:00
Brisanet President José Roberto Nogueira on Turning His Vision for the Semi-Arid Northeast into Reality | José Roberto Nogueira ,CEO, Brisanet Participações SA.
00:10:00
Discover BR Properties' BROF11 Fund with Martin Jaco|CEO , BR Properties SA
00:10:00
Adapting to New Business Realities in South Africa: Challenges and Resilience Amid Logistics and Energy Constraints|DR NOMBASA TSENGWA,CHIEF EXECUTIVE OFFICER,Exxaro Resources Ltd.
00:10:00
Exceptional products that exceed our clients’ expectations|Yasuhiro Yokota,President,Tokio Marine Asset Management (USA) Ltd.
00:10:00
Understanding the Four Pillars of Capital: Insights from Caspar Helmore | Caspar Helmore, Partner - Client Management

© 2017 - Neuhu+